Lupin Ltd, a fifth largest Indian Pharma company with net sales of Rs 3,775 crore, has acquired US rights for Antara (Fenofibrate capsules 43 mg, and 130 mg) for a total consideration of US$ 38.61 crore from Oscient Pharmaceuticals under the procedures of the US Bankruptcy Court. Antara recorded net sales of US$ 70 million for the year 2008.
The details can be read here.
No comments:
Post a Comment